{"id":2822,"date":"2024-05-17T16:00:35","date_gmt":"2024-05-17T16:00:35","guid":{"rendered":"https:\/\/stoxpo.com\/?p=2822"},"modified":"2024-05-17T16:00:36","modified_gmt":"2024-05-17T16:00:36","slug":"amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/","title":{"rendered":"Amgen&#8217;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">New Therapy Offers Hope for Patients With Advanced Small-Cell Lung Cancer, Extending Survival Rates and Quality of Life<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">The Food and Drug Administration (FDA) has granted approval to Amgen&#8217;s (AMGN) groundbreaking therapy, Imdelltra, as a significant breakthrough in the treatment of advanced small-cell lung cancer. This milestone offers renewed hope for patients battling this aggressive form of lung cancer, which has historically presented limited treatment options and dismal survival rates.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Imdelltra, known generically as tarlatamab, has been cleared by the FDA for use as a second or later line of treatment, providing a vital alternative for patients whose cancer has progressed despite previous interventions, such as chemotherapy. Clinical trials have demonstrated Imdelltra&#8217;s remarkable efficacy in reducing tumor growth and significantly prolonging the lives of patients afflicted with small-cell lung cancer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Small-cell lung cancer, accounting for 15% of all lung cancer cases globally, presents a formidable challenge due to its rapid progression and limited treatment options. With the majority of patients diagnosed at an advanced stage of the disease, the need for innovative therapies like Imdelltra is urgent and compelling.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The approval of Imdelltra represents a significant advancement in cancer treatment, offering patients the prospect of prolonged survival and an enhanced quality of life. As ongoing research explores the potential of Imdelltra in earlier stages of small-cell lung cancer and as a first-line treatment, the outlook for patients afflicted with this devastating disease continues to improve. Amgen&#8217;s commitment to advancing cancer therapeutics underscores the importance of continued innovation in the fight against cancer, bringing hope and healing to patients and their families worldwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/microsoft-ventures-into-ai-chip-market-with-amd-collaboration\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Microsoft Ventures into AI Chip Market with AMD Collaboration<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New Therapy Offers Hope for Patients With Advanced Small-Cell Lung Cancer, Extending Survival Rates and Quality of Life The Food and Drug Administration (FDA) has granted approval to Amgen&#8217;s (AMGN) groundbreaking therapy, Imdelltra, as a significant breakthrough in the treatment of advanced small-cell lung cancer. This milestone offers renewed hope for patients battling this aggressive [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1142,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"0","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,361],"tags":[419,451,421,416,418,417],"coauthors":[454],"class_list":["post-2822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-large-cap","tag-breaking","tag-fda","tag-growth","tag-movers","tag-news","tag-stock-market"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amgen&#039;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amgen&#039;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"New Therapy Offers Hope for Patients With Advanced Small-Cell Lung Cancer, Extending Survival Rates and Quality of Life The Food and Drug Administration (FDA) has granted approval to Amgen&#8217;s (AMGN) groundbreaking therapy, Imdelltra, as a significant breakthrough in the treatment of advanced small-cell lung cancer. This milestone offers renewed hope for patients battling this aggressive [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-17T16:00:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-17T16:00:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Blaumann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luca Blaumann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/\"},\"author\":{\"name\":\"Luca Blaumann\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\"},\"headline\":\"Amgen&#8217;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment\",\"datePublished\":\"2024-05-17T16:00:35+00:00\",\"dateModified\":\"2024-05-17T16:00:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/\"},\"wordCount\":289,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"keywords\":[\"Breaking\",\"FDA\",\"Growth\",\"Movers\",\"News\",\"Stock Market\"],\"articleSection\":[\"Biotechnology\",\"Large-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/\",\"name\":\"Amgen's Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"datePublished\":\"2024-05-17T16:00:35+00:00\",\"dateModified\":\"2024-05-17T16:00:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/17\\\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amgen&#8217;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\",\"name\":\"Luca Blaumann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"caption\":\"Luca Blaumann\"},\"description\":\"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/luca-blaumann\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amgen's Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Amgen's Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment - Stoxpo","og_description":"New Therapy Offers Hope for Patients With Advanced Small-Cell Lung Cancer, Extending Survival Rates and Quality of Life The Food and Drug Administration (FDA) has granted approval to Amgen&#8217;s (AMGN) groundbreaking therapy, Imdelltra, as a significant breakthrough in the treatment of advanced small-cell lung cancer. This milestone offers renewed hope for patients battling this aggressive [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/","og_site_name":"Stoxpo","article_published_time":"2024-05-17T16:00:35+00:00","article_modified_time":"2024-05-17T16:00:36+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","type":"image\/jpeg"}],"author":"Luca Blaumann","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luca Blaumann","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/"},"author":{"name":"Luca Blaumann","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806"},"headline":"Amgen&#8217;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment","datePublished":"2024-05-17T16:00:35+00:00","dateModified":"2024-05-17T16:00:36+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/"},"wordCount":289,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","keywords":["Breaking","FDA","Growth","Movers","News","Stock Market"],"articleSection":["Biotechnology","Large-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/","name":"Amgen's Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","datePublished":"2024-05-17T16:00:35+00:00","dateModified":"2024-05-17T16:00:36+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/17\/amgens-imdelltra-receives-fda-approval-as-breakthrough-lung-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Amgen&#8217;s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806","name":"Luca Blaumann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b","url":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","caption":"Luca Blaumann"},"description":"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/luca-blaumann\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=2822"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2822\/revisions"}],"predecessor-version":[{"id":2823,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2822\/revisions\/2823"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1142"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=2822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=2822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=2822"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=2822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}